TG Therapeutics Inc (NASDAQ:TGTX)

13.07
BATS BZX Real-Time Price
As of 2:21pm ET
 -1.27 / -8.86%
Today’s Change
4.42
Today|||52-Week Range
20.00
-17.49%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2011

2012

2013

2014
Revenue and IncomeNet Revenues0.0019.0K152.4K152.4K
 
 
 
 
Depreciation And Amortization0.00235.001.1K3.9K
 
 
 
 
 
Operating ExpensesGross Income0.00--------
General Expenses882.0K25.8M20.3M55.9M
 
 
 
 
 
Research And Development327.3K21.0M13.7M40.1M
 
 
 
 
 
Total Operating Expenses882.0K25.8M20.3M55.9M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-882.0K-25.8M-20.2M-55.7M
 
 
 
 
 
Extraordinary Credit0.001.7M3.3M720.0K
 
 
 
 
Extraordinary Charge0.00-1.1M-2.8M0.00
 
 
 
Interest Expense On Debt7.1K905.7K952.9K930.7K
 
 
 
 
 
Other Expenses0.00272.2K108.9K95.4K
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-889.1K-25.9M-20.5M-55.8M
 
 
 
 
 
Income Taxes0.00-330.0K0.000.00
 
 
Minority Interest-36.0K-8.1M0.000.00
 
 
 
Net Income-853.1K-18.1M-20.5M-55.8M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS34.2K13.1M25.4M34.1M
 
 
 
 
 
Shares To Calculate EPS Diluted34.2K13.1M25.4M34.1M
 
 
 
 
 
 
Earnings Per ShareEPS-$24.75-$1.38-$0.81-$1.64
 
 
 
 
 
EPS Diluted-$24.75-$1.38-$0.81-$1.64
 
 
 
 
 
 

To view my watchlist

Not a member yet?

Sign up now for a free account